First and second apheresis in patients with multiple myeloma: No differences in tumor load and hematopoietic stem cell yield

Bone Marrow Transplantation

Volumn 21, Issue 11, 1998, Pages 1109-1115

  Kiel, K ^a   Cremer, F W ^a   Ehrbrecht, E ^a   Wallmeier, M ^a   Hegenbart, U ^a   Goldschmidt, H ^a   Moos, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Multiple myeloma; Peripheral blood stem cells; Tumor contamination

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; PREDNISONE; VINCRISTINE;

ADULT; APHERESIS; ARTICLE; AUTOGRAFT; CANCER CELL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031833914     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701242     Document Type: Article

References (25)

1. Jagannath S, Vesole D, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood cell support. Blood 1992; 80: 1666-1672.
2. Fermand J, Chervet S, Ravaud P et al. High dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma. Blood 1993; 82: 2005-2009.
3. Vescio RA, Han EJ, Schiller GJ et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant 1996; 18: 103-110.
4. Henry JM, Sykes PJ, Brisco MJ et al. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. Br J Haematol 1996; 92: 614-619.
5. Brenner MK, Rill DR, Moen RC et al. Gene marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
6. Gribben JG, Neuberg D, Freedman et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B cell lymphoma. Blood 1993; 81: 3449-3457.
7. Gertz MA, Witzig TE, Pineda AA et al. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplant 1997; 19: 337-342.
8. Anderson KC, Andersen J. Soiffer R et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-2576.
9. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
10. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
11. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636-640.
12. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
13. Gazitt Y, Tian E, Barlogie B et al. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1996; 87: 805-811.
14. Durie B, Salmon S. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842-852.
15. Goldschmidt H, Hegenbart U, Wallmeier M et al. High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma. Annal Oncol 1997; 8: 1-4.
16. Attal M, Harousseau JL, Stoppa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
17. Murea S, Goldschmidt H, Hahn U et al. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. J Clin Apher 1996; 11: 185-194.
18. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
19. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 15: 3787-3794.
20. Goldschmidt H, Hegenbart U, Wallmeier M et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997; 98: 736-744.
21. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant 1996; 17: 691-697.
22. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-514.
23. Moos M, Schulz R, Cremer FW et al. Detection of minimal residual disease by polymerase chain reaction (PCR) in B cell malignancies. Stem Cells 1995; 13 (Suppl. 3): 42-51.
24. Cremer FW, Kiel K, Wallmeier M et al. A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma. Ann Oncol 1997; 8: 633-636.
25. Brisco MJ, Tan LW, Orsborn AM, Morley AA. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 1990; 75: 163-167.